Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Gastrointestinal Drug market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Gastrointestinal Drug market. Detailed analysis of key players, along with key growth strategies adopted by Gastrointestinal Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria?Tillotts?
Perrigo
Boehringer Ingelheim
Purdue Pharma
Abbott
Jiangzhong
Xian-Janssen
By Type:
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
By End-User:
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Gastrointestinal Drug Market
-
1.3 Market Segment by Type
-
1.3.1 USA Gastrointestinal Drug Market Size and Growth Rate of Prescription Gastrointestinal Drug from 2016 to 2027
-
1.3.2 USA Gastrointestinal Drug Market Size and Growth Rate of OTC Gastrointestinal Drug from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Gastrointestinal Drug Market Size and Growth Rate of Chronic Gastritis from 2016 to 2027
-
1.4.2 USA Gastrointestinal Drug Market Size and Growth Rate of Functional Dyspepsia from 2016 to 2027
-
1.4.3 USA Gastrointestinal Drug Market Size and Growth Rate of Peptic Ulcer from 2016 to 2027
-
1.4.4 USA Gastrointestinal Drug Market Size and Growth Rate of Acute Gastroenteritis from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Gastrointestinal Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Gastrointestinal Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Gastrointestinal Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Gastrointestinal Drug Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Gastrointestinal Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Gastrointestinal Drug by Major Types
-
3.4.1 Market Size and Growth Rate of Prescription Gastrointestinal Drug
-
3.4.2 Market Size and Growth Rate of OTC Gastrointestinal Drug
4 Segmentation of Gastrointestinal Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Gastrointestinal Drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Gastrointestinal Drug in Chronic Gastritis
-
4.4.2 Market Size and Growth Rate of Gastrointestinal Drug in Functional Dyspepsia
-
4.4.3 Market Size and Growth Rate of Gastrointestinal Drug in Peptic Ulcer
-
4.4.4 Market Size and Growth Rate of Gastrointestinal Drug in Acute Gastroenteritis
5 Market Analysis by Regions
-
5.1 USA Gastrointestinal Drug Production Analysis by Regions
-
5.2 USA Gastrointestinal Drug Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Gastrointestinal Drug Landscape Analysis
-
6.1 West USA Gastrointestinal Drug Landscape Analysis by Major Types
-
6.2 West USA Gastrointestinal Drug Landscape Analysis by Major End-Users
7 South USA Gastrointestinal Drug Landscape Analysis
-
7.1 South USA Gastrointestinal Drug Landscape Analysis by Major Types
-
7.2 South USA Gastrointestinal Drug Landscape Analysis by Major End-Users
8 Middle West USA Gastrointestinal Drug Landscape Analysis
-
8.1 Middle West USA Gastrointestinal Drug Landscape Analysis by Major Types
-
8.2 Middle West USA Gastrointestinal Drug Landscape Analysis by Major End-Users
9 Northeast USA Gastrointestinal Drug Landscape Analysis
-
9.1 Northeast USA Gastrointestinal Drug Landscape Analysis by Major Types
-
9.2 Northeast USA Gastrointestinal Drug Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 AstraZenec
-
10.1.1 AstraZenec Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Sanofi
-
10.2.1 Sanofi Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Bayer
-
10.3.1 Bayer Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Pfizer
-
10.4.1 Pfizer Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 GlaxoSmithKline
-
10.5.1 GlaxoSmithKline Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Teva
-
10.6.1 Teva Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Zeria?Tillotts?
-
10.7.1 Zeria?Tillotts? Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Perrigo
-
10.8.1 Perrigo Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Boehringer Ingelheim
-
10.9.1 Boehringer Ingelheim Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Purdue Pharma
-
10.10.1 Purdue Pharma Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Abbott
-
10.11.1 Abbott Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Jiangzhong
-
10.12.1 Jiangzhong Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 Xian-Janssen
-
10.13.1 Xian-Janssen Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Gastrointestinal Drug Market Size and Growth Rate of Prescription Gastrointestinal Drug from 2016 to 2027
-
Figure USA Gastrointestinal Drug Market Size and Growth Rate of OTC Gastrointestinal Drug from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Gastrointestinal Drug Market Size and Growth Rate of Chronic Gastritis from 2016 to 2027
-
Figure USA Gastrointestinal Drug Market Size and Growth Rate of Functional Dyspepsia from 2016 to 2027
-
Figure USA Gastrointestinal Drug Market Size and Growth Rate of Peptic Ulcer from 2016 to 2027
-
Figure USA Gastrointestinal Drug Market Size and Growth Rate of Acute Gastroenteritis from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Gastrointestinal Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Gastrointestinal Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Gastrointestinal Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Gastrointestinal Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Gastrointestinal Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Gastrointestinal Drug
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Gastrointestinal Drug by Different Types from 2016 to 2027
-
Table Consumption Share of Gastrointestinal Drug by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Prescription Gastrointestinal Drug
-
Figure Market Size and Growth Rate of OTC Gastrointestinal Drug
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Gastrointestinal Drug by Different End-Users from 2016 to 2027
-
Table Consumption Share of Gastrointestinal Drug by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Chronic Gastritis
-
Figure Market Size and Growth Rate of Functional Dyspepsia
-
Figure Market Size and Growth Rate of Peptic Ulcer
-
Figure Market Size and Growth Rate of Acute Gastroenteritis
-
Table USA Gastrointestinal Drug Production by Regions
-
Table USA Gastrointestinal Drug Production Share by Regions
-
Figure USA Gastrointestinal Drug Production Share by Regions in 2016
-
Figure USA Gastrointestinal Drug Production Share by Regions in 2021
-
Figure USA Gastrointestinal Drug Production Share by Regions in 2027
-
Table USA Gastrointestinal Drug Consumption by Regions
-
Table USA Gastrointestinal Drug Consumption Share by Regions
-
Figure USA Gastrointestinal Drug Consumption Share by Regions in 2016
-
Figure USA Gastrointestinal Drug Consumption Share by Regions in 2021
-
Figure USA Gastrointestinal Drug Consumption Share by Regions in 2027
-
Table West USA Gastrointestinal Drug Consumption by Types from 2016 to 2027
-
Table West USA Gastrointestinal Drug Consumption Share by Types from 2016 to 2027
-
Figure West USA Gastrointestinal Drug Consumption Share by Types in 2016
-
Figure West USA Gastrointestinal Drug Consumption Share by Types in 2021
-
Figure West USA Gastrointestinal Drug Consumption Share by Types in 2027
-
Table West USA Gastrointestinal Drug Consumption by End-Users from 2016 to 2027
-
Table West USA Gastrointestinal Drug Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Gastrointestinal Drug Consumption Share by End-Users in 2016
-
Figure West USA Gastrointestinal Drug Consumption Share by End-Users in 2021
-
Figure West USA Gastrointestinal Drug Consumption Share by End-Users in 2027
-
Table South USA Gastrointestinal Drug Consumption by Types from 2016 to 2027
-
Table South USA Gastrointestinal Drug Consumption Share by Types from 2016 to 2027
-
Figure South USA Gastrointestinal Drug Consumption Share by Types in 2016
-
Figure South USA Gastrointestinal Drug Consumption Share by Types in 2021
-
Figure South USA Gastrointestinal Drug Consumption Share by Types in 2027
-
Table South USA Gastrointestinal Drug Consumption by End-Users from 2016 to 2027
-
Table South USA Gastrointestinal Drug Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Gastrointestinal Drug Consumption Share by End-Users in 2016
-
Figure South USA Gastrointestinal Drug Consumption Share by End-Users in 2021
-
Figure South USA Gastrointestinal Drug Consumption Share by End-Users in 2027
-
Table Middle West USA Gastrointestinal Drug Consumption by Types from 2016 to 2027
-
Table Middle West USA Gastrointestinal Drug Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Gastrointestinal Drug Consumption Share by Types in 2016
-
Figure Middle West USA Gastrointestinal Drug Consumption Share by Types in 2021
-
Figure Middle West USA Gastrointestinal Drug Consumption Share by Types in 2027
-
Table Middle West USA Gastrointestinal Drug Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Gastrointestinal Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Gastrointestinal Drug Consumption Share by End-Users in 2016
-
Figure Middle West USA Gastrointestinal Drug Consumption Share by End-Users in 2021
-
Figure Middle West USA Gastrointestinal Drug Consumption Share by End-Users in 2027
-
Table Northeast USA Gastrointestinal Drug Consumption by Types from 2016 to 2027
-
Table Northeast USA Gastrointestinal Drug Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Gastrointestinal Drug Consumption Share by Types in 2016
-
Figure Northeast USA Gastrointestinal Drug Consumption Share by Types in 2021
-
Figure Northeast USA Gastrointestinal Drug Consumption Share by Types in 2027
-
Table Northeast USA Gastrointestinal Drug Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Gastrointestinal Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Gastrointestinal Drug Consumption Share by End-Users in 2016
-
Figure Northeast USA Gastrointestinal Drug Consumption Share by End-Users in 2021
-
Figure Northeast USA Gastrointestinal Drug Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of AstraZenec
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZenec
-
Figure Sales and Growth Rate Analysis of AstraZenec
-
Figure Revenue and Market Share Analysis of AstraZenec
-
Table Product and Service Introduction of AstraZenec
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Teva
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva
-
Figure Sales and Growth Rate Analysis of Teva
-
Figure Revenue and Market Share Analysis of Teva
-
Table Product and Service Introduction of Teva
-
Table Company Profile and Development Status of Zeria?Tillotts?
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zeria?Tillotts?
-
Figure Sales and Growth Rate Analysis of Zeria?Tillotts?
-
Figure Revenue and Market Share Analysis of Zeria?Tillotts?
-
Table Product and Service Introduction of Zeria?Tillotts?
-
Table Company Profile and Development Status of Perrigo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Perrigo
-
Figure Sales and Growth Rate Analysis of Perrigo
-
Figure Revenue and Market Share Analysis of Perrigo
-
Table Product and Service Introduction of Perrigo
-
Table Company Profile and Development Status of Boehringer Ingelheim
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim
-
Table Product and Service Introduction of Boehringer Ingelheim
-
Table Company Profile and Development Status of Purdue Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma
-
Figure Sales and Growth Rate Analysis of Purdue Pharma
-
Figure Revenue and Market Share Analysis of Purdue Pharma
-
Table Product and Service Introduction of Purdue Pharma
-
Table Company Profile and Development Status of Abbott
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott
-
Figure Sales and Growth Rate Analysis of Abbott
-
Figure Revenue and Market Share Analysis of Abbott
-
Table Product and Service Introduction of Abbott
-
Table Company Profile and Development Status of Jiangzhong
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jiangzhong
-
Figure Sales and Growth Rate Analysis of Jiangzhong
-
Figure Revenue and Market Share Analysis of Jiangzhong
-
Table Product and Service Introduction of Jiangzhong
-
Table Company Profile and Development Status of Xian-Janssen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Xian-Janssen
-
Figure Sales and Growth Rate Analysis of Xian-Janssen
-
Figure Revenue and Market Share Analysis of Xian-Janssen
-
Table Product and Service Introduction of Xian-Janssen
-
